Chargement en cours...

Single‐dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women

PURPOSE: Recombinant hCG (r‐hCG) was approved in Japan in 2016. As a prerequisite for a Phase III study in Japan related to this approval, the pharmacokinetic (PK) profile of r‐hCG was investigated. METHODS: An open‐label, partly randomized, single‐center, single‐dose, group‐comparison, Phase I PK‐b...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Reprod Med Biol
Auteurs principaux: Bagchus, Wilhelmina, Wolna, Peter, Uhl, Wolfgang
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5768983/
https://ncbi.nlm.nih.gov/pubmed/29371821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rmb2.12066
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!